Epidemiology and economic impact of heart failure in France;Epidemiologie et impact economique de l'insuffisance cardiaque en France

Archives des Maladies du Coeur et des Vaisseaux

Volumn 91, Issue 11, 1998, Pages 1307-1314

  Delahaye, F ^b   De Gevigney, G ^b   Gaillard, S ^b   Cheneau, E ^a  

^a Hop Cardiol Vasculaire/P

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BISOPROLOL; CARVEDILOL; DIGOXIN; ENALAPRIL; HYDRALAZINE; ISOSORBIDE DINITRATE; METOPROLOL;

AGE; ARTICLE; CLINICAL TRIAL; FRANCE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; PREVALENCE; PROGNOSIS; SEX DIFFERENCE; AGED; CONGESTIVE HEART FAILURE; FEMALE; HOSPITALIZATION; INCIDENCE; MALE; MIDDLE AGED; PREVENTIVE MEDICINE; PUBLIC HEALTH; STATISTICS;

AGE FACTORS; AGED; FEMALE; FRANCE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVENTIVE MEDICINE; PUBLIC HEALTH;

EID: 0031795837     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Gibson TC, White KL, Klainer LM. The prevalence of congestive heart failure in two rural communities. J Chron Dis 1966 ; 19 : 141-52.
2. Klainer LM, Gibson TC, White KL. The epidemiology of cardiac failure. J Chron Dis 1965; 18 : 797-814.
3. Kannel WB, Belanger AJ. Epidemioloqy of heart failure. Am Heart J 1991 ; 121 : 951-7.
4. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med 1971 ; 285 : 1441-6.
5. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993 ; 22 : A6-A13.
6. Epstein FH, Ostrander LD. Johnson BC et al. Epidemiological studies of cardiovascular disease in a total community - Tecumseh, Michigan. Ann Intern Med 1965 ; 62 : 1170-87.
7. Garrison GE, McDonough JR, Hames CG, Stulb SC. Prevalence of chronic congestive heart failure in the population of Evans County, Georgia. Am J Epidemiol 1966 ; 83 : 338-44.
8. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992 ; 20 : 301-6.
9. Rodeheffer RJ, Jacobsen SJ, Gersh BJ et al. The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc 1993 ; 68: 1143-50.
10. Phillips SJ, Whisnant JP, O'Fallon WM, Frye RL. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 1990 ; 65 : 344-59.
11. Mittelmark MB, Psaty BM, Rautaharju PM et al. Prevalence of cardiovascular diseases among older adults. The Cardiovascular Health Study. Am J Epidemiol 1993 ; 137 : 311-7.
12. Droller H, Pemberton J. Cardiovascular disease in a random sample of elderly people. Br Heart J 1953 ; 15: 199-204.
13. Eriksson H, Svärdsudd K, Larsson B et al. Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J 1989 ; 10: 647-56.
14. Wilhelmsen L, Eriksson H, Svärdsudd K, Caidahl K. Improving the detection and diagnosis of congestive heart failure. Eur Heart J 1989; 10 (suppl C) : 13-8.
15. Landahl S, Svanborg A, Astrand K. Heart volume and the prevalence of certain common cardiovascular disorders at 70 and 75 years of age. Eur Heart J 1984 ; 5: 326-31.
16. Parameshwar J, Shocked MM, Richardson A, Poole-Wilson PA, Sutton GC. Prevalence of heart failure in three general practices in north west London. Br J Gen Pract 1992 ; 42 : 287-9.
17. Lamberts H, Brouwer HJ, Mohrs J. Reason for encounter - and episode and process oriented standard output from the Transition Project. Part 1 and 2. Amsterdam : Dept of general practice, 1993.
18. Van de Lisdonk EH, Van den Bosch WJHM, Huygen FJA, Lagro-Jansen ALM. Diseases in general practice. Utrecht, Pays Bas : Bunge, 1990.
19. Ambrosia GB, Riva LM, Zamboni S et al. Heart failure in the population: prevalence data. Cardiologia 1992 ; 37: 685-91.
20. Ambrosio GB, Riva LM, Casiglia E. Prevalence of congestive heart failure (CHF) in elderly. A survey from a population in Veneto region. Acta Cardiologica 1994 ; 49: 324-5.
21. Wendelboe O, Hansen JF. Prevalence of mild and severe congestive heart failure in the community. Heart Failure 95, International meeting of the working group on heart failure or the European Society of Cardiology, 1-4 avril 1995, Amsterdam (abstract).
22. Clarke KW, Gray D, Hampton JR. The prevalence of heart failure estimated from prescription data. Br Heart J 1994 ; 71 (suppl) : 33-7.
23. Royal College of General Practitioners, Office of population census and survey, and department of health and social security. Morbidity statistics from general practice : fourth national study, 1991-1992. London : HMSO, 1995.
24. Remes J, Reunanen A, Aromaa A, Pyörälä K. Incidence of heart failure in eastern Finland : a population-based surveillance study. Eur Heart J 1992 ; 13 : 588-93.
25. Teerlink JR, Goldhaber SZ, Pfeffer MA. An overview of contemporary etiologies of congestive heart failure. Am Heart J 1991 ; 121: 1852-3.
26. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure. The Fromingham Study. N Engl J Med 1972 ; 287 : 781-7.
27. Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J 1994 ; 72 (suppl) : S3-S9.
28. Killip T. Epidemiology of congestive heart failure. Am J Cardiol 1985 ; 56 : A2-A6.
29. Cowie MR, Wood DA, Coats A et al. Incidence and aetiology of heart failure in the general population. Heart 1997 ; 77 (suppl 1) : P7 (abstract).
30. Kannel WB. Needs and prospects for prevention of cardiac failure. Eur J Clin Pharmacol 1996 ; 49 : S3-S9.
31. CONSENSUS Trial Study Group. Effects of enalapril on morta lity in severe congestive neart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med 1987 ; 316 : 1429-35.
32. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991 ; 325 : 293-302.
33. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992 ; 327 : 685-91.
34. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995 ; 273 : 1450-6.
35. CIBIS Investigators and Committees. A randomized trial of β-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994 ; 90 : 1765-73
36. Waagstein F, Bristow MR, Swedberg K et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993 ; 342 : 1441-6.
37. Australia-New Zealand Heart Failure Research Collaborative Group. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 1997 ; 349 : 375-80.
38. Packer M, Bristow MR, Cohn JN, et al, for the US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996 ; 334 : 1349-55.
39. Cohn JN, Archibald DG, Ziesche S et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986 ; 314 : 1547-52.
40. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R, for the GESICA group. Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994 ; 344 : 493-8.
41. Singh SN, Fletcher RD, Fisher SG et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmias. N Engl J Med 1995 ; 333 : 77-82.
42. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997 ; 336 : 525-33.
43. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset or congestive heart failure in Framingham Heart Study subjects. Circulation 1993 ; 88 : 107-15.
44. Goldman L, Cook EF. The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med 1984 ; 104 : 825-36.
45. Yamani M, Massie BM. Congestive heart Failure: insights from epidemiology, implications for treatment. Mayo Clin Proc 1993 ; 68 : 1214-8
46. McMurray J, McDonogh T, Morrison CE, Dorgie HJ. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J 1993 ; 14 : 1158-62.
47. Reitsma JB, Mosterd A, Koster RW et al. Increase in the number of admissions due to heart failure in Dutch hospitals in the period 1980-1992. Ned Tijdschr Geneeskd 1994 ; 138 : 866-71.
48. Eriksson H, Wilhelmsen L, Caidahl K, Svardsudd K. Epidemiology and prognosis of heart failure. Z Kardiol 1991 ; 80 (suppl 8): 1-6.
49. Eriksson H. Heart failure. A growing health problem. J Intern Med 1995 ; 237 : 135-41.
50. Dinkel R, Buchner K, Holtz J. Chronic heart failure. Socio economic relevance in the Federal Republic of Germany. Munch Med Wochenschr 1989 ; 131 : 686-9.
51. Koopmanschap MA. Van Roijen L, Bonneux L. Costs of diseases in the Netherlands. Report of the department of public health and social medicine and me institute for medical technology assessment. Rotterdam : Erasmus University, 1992.
52. McMurray J, Hart W, Rhodes G. An evaluation of the economic cost of heart failure to the National Health Service in the United Kingdom. Br J Med Econ 1993 ; 6 : 99-110.
53. Ounnoughène Z. Epidémiologie de l'insuffisance cardiaque. D'après la communication de A. Castaigne sur l'épidémiologie de l'insuffisance cardiaque en 1997 à la SPIF. Cardiologie Pratique 1998 ; 441 : 6-8.